Join industry leaders Meri Beckwith, Malcolm Fogarty from Lindus Health and Dr Thomas Gurry from Myota for a live webinar on how consumer health brands can run faster, leaner and claims-ready clinical trials. Secure your spot today.
In consumer health, clinical evidence is now the currency of competitive advantage.
Consumers are better informed and more discerning than ever. They expect proof that products deliver real results, and they’re quick to turn away from brands that can’t back up their claims.
In this environment, credible, transparent clinical evidence is what differentiates leaders.
Yet many brands still face a common challenge: traditional, pharma-style trials are too slow, too costly, and poorly suited to the realities of consumer health.
Rigid protocols and lengthy timelines often miss what really matters—real-world consumer outcomes.
A new model for generating science-backed evidence
Innovative sponsors are now building trials explicitly designed for consumer health: faster, leaner and engineered for richer insights.
These modern approaches balance speed, cost, and scientific credibility, delivering data that meets regulatory standards and drives commercial success.
Today’s most successful brands are breaking from that model, embracing right-sized, claims-first trials.
This modern approach centers on three key principles that make consumer health research faster, smarter and commercially impactful.
1. Claims-first design
Effective consumer health studies begin with the claims that will ultimately appear on packaging, marketing, or retail.
Trial protocols are increasingly aligned with those intended claims, linking each to measurable, regulator-accepted endpoints.
2. Lean, hybrid execution.
Digital tools like eConsent, remote monitoring and targeted online recruitment are transforming timelines.
Decentralized and adaptive designs enable more inclusive studies that reflect real consumer use, without compromising data quality.
3. Real-world scalability
Evidence strategies are also being designed with global reach in mind.
Harmonised protocols and adaptive designs allow sponsors to collect and analyse data consistently across markets, ensuring claims remain credible and translatable from one region to another.
Learn from consumer health industry leaders
In this upcoming webinar, Meri Beckwith and Malcolm Fogarty from Lindus Health, together with Dr Thomas Gurry from Myota, will share how innovative trial designs, from decentralized studies to real-world evidence approaches, are transforming clinical validation for consumer health brands.
You’ll gain practical insights on how to:
- Generate medical-grade data at consumer-scale budgets
- Balance speed, cost, and credibility in trial design
- Turn credible clinical evidence into commercial advantage
Register here to learn how leading consumer health brands are using science-backed trials to strengthen claims and build lasting consumer trust.
